As a managing partner for Laidlaw & Company, James “Jim” Ahern advises and raises capital for public and private healthcare companies. When he isn’t busy working for Laidlaw, James “Jimmy” Ahern enjoys following his favorite National Football League (NFL) team, the New England Patriots.
The Patriots became the first NFL team to overcome a 25-point deficit in the Super Bowl when the team rallied to beat the Atlanta Falcons 34-28 in 2016 and now the franchise has established another first. The Patriots recently bought a pair of 767 Boeing wide-body jets and, in doing so, became the first NFL team to purchase its own air transportation. The planes were purchased in the summer of 2017 and will be used by the team to fly to games throughout the upcoming season. First-class seats with reclining capability were added throughout the plane, while the exterior is decorated with the Patriots logo and five Lombardi trophies.
An ESPN source indicated that the planes are extended range, meaning they can fly nonstop for up to 12 hours. Depending on their condition, 767 Boeing planes can cost upwards of $65 million, while a brand-new one can be worth as much as $200 million. The decision to buy the planes stems from recent announcements from major airlines that they would soon be retiring the bigger planes used to accommodate NFL teams. Last year, American Airlines cut ties with six NFL teams, two of which began using Miami Air, a charter-only airline.
An experienced financial executive, James “Jimmy” Ahern serves as head of capital markets at Laidlaw & Company, for which he raises money for and advises public and private health care companies. Beyond his professional responsibilities with Laidlaw, James Ahern is a passionate fan of Major League Baseball’s (MLB) Boston Red Sox.
Hoping to make the playoffs for the second consecutive season, the Red Sox bolstered its bullpen on July 31, MLB’s trade deadline day, by acquiring relief pitcher Addison Reed from the New York Mets in exchange for three pitching prospects. Reed, who is expected to become Boston’s eighth-inning setup man for closer Craig Kimbrel, first joined the Mets in the middle of the 2015 season. In nearly two years with the club, the 28 year old compiled a 2.09 earned run average (ERA) in 142 innings and saved 19 games while closer Jeurys Familia was injured.
Boston sent the Mets Gerson Bautista, Stephen Nogosek, and Jamie Callahan in the deal. All three were ranked among the Red Sox’ top 30 prospects by MLB.com. Bautista and Nogosek are still pitching in A-ball, while Callahan was most recently pitching for Boston’s Triple-A affiliate in Pawtucket.
An experienced New York executive, James Ahern engages with Laidlaw & Company as its managing partner and head of capital markets. In his role as an investment banker, James “Jimmy” Ahern focuses on the healthcare market, with invested companies including PhaseRx and Gemphire.
In March of 2017, Jimmy Ahern and his colleagues served as the sole book runner, or main underwriter, in guiding a common stock initial public offering for Therapix Biosciences that raised $13.8 million in capital participation. Headquartered in Tel Aviv, Israel, Therapix Biosciences has developed dronabinol as a way of repurposing FDA-approved synthetic cannabinoids for therapeutic purposes involving new indications.
Current internal programs of Therapix Biosciences include a Phase 1 study of THX-ULD01, or BrainBright Pharma, in treating mild cognitive impairment, and a Phase 2b trial of THX-TS01, or Joint Pharma, for patients with Tourette’s syndrome.